Healthcare IT & Genomics

Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.

Analyst Insights

Clinical Data: How to Monetisation for Real-World Use

23rd November – In this insight, we discuss the BioTechX conference in Basel and what the conference’s discourse revealed about cRWD and it’s potential over the next few years.

Signify Premium Insight: Amazon in Prime Position with HealthLake Plans

Signify Premium Insights Subscription Required

22nd November 2022 – Amazon, like several of its Big Tech peers, has redoubled its efforts in medical imaging. The Seattle-based firm makes some bold claims, but will they be enough to win custom away from its rivals?

Adoption of Cloud Intensifies in Imaging IT

Cloud continues to take top billing as a trend in imaging informatics and wider healthcare. Has the promise and momentum from COVID-19 for cloud adoption intensified? Or is cloud adoption hamstrung by impending economic headwinds, health provider organisational complexity and ethico-legal concern around patient data privacy?

Signify Premium Insight: Annalise Hoping to get Comprehensively Ahead

Signify Premium Insights Subscription Required

10th November 2022 – With the release of its solution for Head CT, Annalise.ai has stuck to its comprehensive approach to medical imaging AI. Providers might be keen, but will regulators allow such a strategy?

Signify Premium Insight: Tempus’ Arterys Acquisition and AI’s Turning Tide

Signify Premium Insights Subscription Required

8th November 2022 – In one of medical imaging AI’s largest acquisitions to date, Tempus has acquired medical imaging AI vendor Arterys. The move will bolster Tempus’ AI offerings, but what does it mean for Arterys’ own ambitions?